IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Euclidean Capital LLC

Q2 2023 Holdings

Filed 2023-08-14 | 12 holdings | $389.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Spdr S&P 500 ETF TR(SPY)TR UNIT78462F103$109.2M246,25028.1%
Ishares TR(INDA)MSCI INDIA ETF46429B598$106.0M2,425,14427.2%
Spdr Gold TR(GLD)GOLD SHS78463V107$98.9M555,00025.4%
23Andme Holding CoCLASS A COM90138Q108$17.9M10,243,1224.6%
PMV Pharmaceuticals Inc(PMVP)COM69353Y103$15.9M2,545,2424.1%
Foghorn Therapeutics Inc(FHTX)COM344174107$11.1M1,573,7612.8%
Rapt Therapeutics Inc(RAPTEUR)COM75382E109$10.7M571,2332.7%
Alector Inc(ALEC)COM014442107$5.9M980,8941.5%
Oric Pharmaceuticals Inc(ORIC)COM68622P109$5.8M747,5501.5%
Tenaya Therapeutics Inc(TNYA)COM87990A106$5.4M915,7051.4%
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$1.9M746,6740.5%
Surrozen IncCOM86889P109$441.6K802,9630.1%